Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fertility preservation in patients with breast cancer using oocyte cryopreservation with follitropin alfa and letrozole
2009-014601-13Phase 2Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Feb 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of follitropin alfa and letrozole in breast cancer, sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoints: Number of oocytes stored per patient and Safety of ovarian stimulation regimen. Started Feb 2011; status: completed.
02
Drugs
follitropin alfaletrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2009-014601-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014601-13.